English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 2/5 criteria met.
- ✅ Price trend passed
- ⚠️ Mixed growth
- ❌ Debt failed
- ❌ P/E failed
- ✅ Correction passed
Price trend
Overall trend (8 years): the price has been multiplied by at least 1.5.
Price change 2018 → 2019: 148.65%
Price change 2019 → 2020: -49.58%
Price change 2020 → 2021: -42.60%
Price change 2021 → 2022: 9.31%
Price change 2022 → 2023: -70.14%
Price change 2023 → 2024: 160.86%
Price change 2024 → 2025: 35.50%
Price change 2025 → 2026: 82.32%
Price change 2026 (year to date): 86.53%
Financial growth
Revenue CAGR (8 years): 5.21%
Earnings CAGR (8 years): N/A
Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.
Debt
Debt-to-equity ratio: 2.70
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -5.85
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 11.14% from the high over 6 months.
Correction between 10.0% and 20.0% (target range).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="QURE" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| uniQure N.V. | – | 2.70 | – | 🔒 |
| Emeis | – | 6.11 | +11.4 % | – |
| Fleury S.A. | 16.6 | 1.05 | +16.2 % | – |
| Clariane SE | 574.8 | 2.16 | +12.4 % | – |
| Addus HomeCare Corporation | 18.8 | 0.19 | +11.7 % | ★ 4/5 |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by uniQure N.V. over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 37.5 m | -125 m | -333.3 % | n/a |
| 2021 | 524 m | 330 m | 62.9 % | +1,296.8 % |
| 2022 | 106 m | -127 m | -119.1 % | -79.7 % |
| 2023 | 15.8 m | -308 m | -1,947.1 % | -85.1 % |
| 2024 | 27.1 m | -240 m | -883.4 % | +71.2 % |
| 2025 | 16.1 m | -199 m | -1,236.0 % | -40.6 % |
Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.
Accounts and financial health
Balance sheet and cash flow published by uniQure N.V. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 556 m | 353 m | 618 m | 368 m | 623 m |
| Total Debt | 136 m | 143 m | 138 m | 66.1 m | 537 m |
| Net Debt | -421 m | -85.1 m | -103 m | -92.9 m | 456 m |
| Equity | 596 m | 476 m | 208 m | -6.8 m | 199 m |
| Total assets | 809 m | 705 m | 832 m | 557 m | 825 m |
| Operating cash flow | 288 m | -145 m | -146 m | -183 m | -178 m |
| Investments (capex) | 17.4 m | 17.7 m | 7.2 m | 11.7 m | 438,999 |
| Free cash-flow | 271 m | -163 m | -153 m | -186 m | -178 m |
| Share buybacks | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.
Analyst consensus and forecasts
What the financial analysts covering uniQure N.V. publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Average target over the last 3 months: 46.00 USD (5 targets).
Track record against expectations: reported EPS above consensus 7 times over the last 12 releases.
Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.
Dividends and earnings
uniQure N.V.: dividend history, last distributions, stock splits and earnings releases.
No known dividend for this company.
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 29/07/2026 | -1.22 | -0.82 | n/a |
| 05/05/2026 | -0.85 | -0.88 | n/a |
| 02/03/2026 | -0.56 | -0.93 | n/a |
| 10/11/2025 | -1.38 | -0.85 | n/a |
| 29/07/2025 | -0.69 | -0.89 | n/a |
| 09/05/2025 | -0.82 | -1.07 | n/a |
Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.
PEA and practical information
Frequently asked questions about uniQure N.V.
What is the uniQure N.V. share price?
Latest recorded price: 21.70 USD on 06/11/2026, for a market cap of 1.5 bn USD.
What is the revenue of uniQure N.V.?
16.1 m USD for fiscal year 2025, with net income of -199 m USD (net margin -1,236.0 %).
What do analysts say about uniQure N.V.?
Out of 38 analysts: 32 buy or strong buy, 6 hold, 0 sell or strong sell. Average price target: 46.00 USD, i.e. +85.3 % from the share price.
How many employees does uniQure N.V. have?
209 full-time employees according to the latest published profile.
Who runs uniQure N.V.?
Matthew Craig Kapusta CPA is the company's chief executive.